Overexpression of estrogen receptor beta and its prognostic significance among malignant pleural mesothelioma patients

被引:0
|
作者
Helali, Mariam [1 ,3 ]
Abdelmotal, Ahmed [1 ]
Gobran, Nagy [1 ]
El Ghazaly, Hesham [1 ]
El Mahdy, Manal [2 ]
Karim, Khaled [1 ]
机构
[1] Ain Shams Univ, Fac Med, Clin Oncol Dept, Cairo, Egypt
[2] Ain Shams Univ, Fac Med, Pathol Dept, Cairo, Egypt
[3] 38 Abbassia,Next Al Nour Mosque, Cairo, Egypt
关键词
mesothelioma; ER beta; prognostic; biomarkers; HEALTH;
D O I
10.4103/ecdt.ecdt_25_23
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background The overexpression of estrogen receptor beta (ER beta) and its correlation with prognosis of malignant mesothelioma remains controversial and unexplored. This study aimed at studying ER beta expression in tumour tissue in patients with pleural mesothelioma and its association with clinical and pathological factors and survival analysis. Material and methods A prospective cohort study was conducted on patients who were diagnosed with malignant pleural mesothelioma (MPM) in Ain Shams university hospitals, the primary end point was to correlate ER beta overexpression that was analysed by immunohistochemistry (IHC) on paraffin tissue blocks with 1-year overall survival (OS) among MPM patients, the secondary endpoint was to correlate ER beta overexpression with 1-year progression free survival (PFS) and response to platinum-based chemotherapy among MPM patients. Results A total 42 MPM patients were included, High ER beta expression (modified Allred score 7-9) was reported in 9.5% of the patients (4 cases), moderate expression (modified Allred score 4-6) was reported in 28.6% of the patients(12 cases), weak and negative expression ( modified Allred score 0-3) was reported in 61% of the patients(26 cases), percent of ER beta positive cases was 69% of the total patients, there was no statistical difference as regard age (p value:0.8), sex(p value:0.4), stage (p value: 0.71), ECOG (p value :0.84) , histological subtype(p value:0.17) and response to platinum based treatment (p value:0.5) across the 3 groups of patients (high, moderate , weak and negative ER beta on tumour tissues) there was no statistically significant difference in OS and PFS for ER beta overexpression. Conclusion The overexpression of ER beta was not associated with improved OS or PFS in mesothelioma patients, despite high rate of ER beta positive cases in our analysis, larger sample size would be recommended for more solid conclusions
引用
收藏
页码:85 / 90
页数:6
相关论文
共 50 条
  • [31] The presence of pleural effusion is an independent prognostic factor in patients with malignant pleural mesothelioma
    Wang, Haoyu
    Yang, Ruiyuan
    Liu, Dan
    Li, Weimin
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [32] Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells
    Manente, Arcangela G.
    Pinton, Giulia
    Zonca, Sara
    Cilli, Michele
    Rinaldi, Maurizio
    Daga, Antonio
    Nilsson, Stefan
    Moro, Laura
    ONCOTARGET, 2015, 6 (28) : 25121 - 25134
  • [33] Utility Of Prognostic Tools In Unselected Patients With Malignant Pleural Mesothelioma
    Teagle, A. R.
    Wollerton, R.
    Goodliffe, J.
    Slade, M. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [34] Prognostic significance of nuclear grade in malignant pleural mesothelioma: A single institution experience
    Erbil, S.
    Yaman, B.
    Cevik, A.
    Ertan, Y.
    Ozdil, A.
    Veral, A.
    Nart, D.
    VIRCHOWS ARCHIV, 2016, 469 : S134 - S134
  • [35] Prognostic significance of soluble mesothelin in malignant pleural mesothelioma: a meta-analysis
    Tian, Long
    Zeng, Rujun
    Wang, Xin
    Shen, Cheng
    Lai, Yutian
    Wang, Mingming
    Che, Guowei
    ONCOTARGET, 2017, 8 (28) : 46425 - 46435
  • [36] Prognostic significance of neutrophil-to-lymphocyte ratio in patients with malignant pleural mesothelioma: a meta-analysis
    Chen, Nan
    Liu, Shuai
    Huang, Lin
    Li, Wanling
    Yang, Wenhao
    Cong, Tianxin
    Ding, Lin
    Qiu, Meng
    ONCOTARGET, 2017, 8 (34) : 57460 - 57469
  • [37] Immunohistochemistry as Prognostic Markers for Malignant Pleural Mesothelioma
    Otsuki, Taiichiro
    Maehashi, Nobuko
    Kataoka, Yuki
    Terada, Takayuki
    Kuribayashi, Kozo
    Hirabayashi, Masataka
    Ieki, Ryuji
    Nakano, Takashi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S505 - S505
  • [38] Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma
    Yamada, Shusai
    Tabata, Chiharu
    Tabata, Rie
    Fukuoka, Kazuya
    Nakano, Takashi
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (10) : 1721 - 1726
  • [39] Biomarkers and prognostic factors for malignant pleural mesothelioma
    Vigneri, Paolo
    Martorana, Federica
    Manzella, Livia
    Stella, Stefania
    FUTURE ONCOLOGY, 2015, 11 (24) : 29 - 33
  • [40] Pleural fluid findings as prognostic factors for malignant pleural mesothelioma
    Gonlugur, Tanseli Efeoglu
    Gonlugur, Ugur
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2008, 22 (05) : 334 - 336